LIS-22
N/A
Report date: 2023/10/11 13:13:28
Base Information
Drug NameLIS-22
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXenothera Sas
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A